These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 31912158)

  • 1. SWI/SNF complex heterogeneity is related to polyphenotypic differentiation, prognosis, and immune response in rhabdoid tumors.
    Panwalkar P; Pratt D; Chung C; Dang D; Le P; Martinez D; Bayliss JM; Smith KS; Adam M; Potter S; Northcott PA; Mascarenhas L; Shows J; Pawel B; Margol A; Huang A; Judkins AR; Venneti S
    Neuro Oncol; 2020 Jun; 22(6):785-796. PubMed ID: 31912158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent co-inactivation of the SWI/SNF subunits SMARCB1, SMARCA2 and PBRM1 in malignant rhabdoid tumours.
    Rao Q; Xia QY; Wang ZY; Li L; Shen Q; Shi SS; Wang X; Liu B; Wang YF; Shi QL; Ma HH; Lu ZF; He Y; Zhang RS; Yu B; Zhou XJ
    Histopathology; 2015 Jul; 67(1):121-9. PubMed ID: 25496315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SWI/SNF complex-deficient soft tissue neoplasms: An update.
    Schaefer IM; Hornick JL
    Semin Diagn Pathol; 2021 May; 38(3):222-231. PubMed ID: 32646614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hereditary SWI/SNF complex deficiency syndromes.
    Agaimy A; Foulkes WD
    Semin Diagn Pathol; 2018 May; 35(3):193-198. PubMed ID: 29397238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SWI/SNF deficient central nervous system neoplasms.
    Cai C
    Semin Diagn Pathol; 2021 May; 38(3):167-174. PubMed ID: 33762087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SWI/SNF-deficient neoplasms of the genitourinary tract.
    Sirohi D; Ohe C; Smith SC; Amin MB
    Semin Diagn Pathol; 2021 May; 38(3):212-221. PubMed ID: 33840529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms by which SMARCB1 loss drives rhabdoid tumor growth.
    Kim KH; Roberts CW
    Cancer Genet; 2014 Sep; 207(9):365-72. PubMed ID: 24853101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BRD9 defines a SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors.
    Wang X; Wang S; Troisi EC; Howard TP; Haswell JR; Wolf BK; Hawk WH; Ramos P; Oberlick EM; Tzvetkov EP; Ross A; Vazquez F; Hahn WC; Park PJ; Roberts CWM
    Nat Commun; 2019 Apr; 10(1):1881. PubMed ID: 31015438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivating mutations in SWI/SNF chromatin remodeling genes in human cancer.
    Oike T; Ogiwara H; Nakano T; Yokota J; Kohno T
    Jpn J Clin Oncol; 2013 Sep; 43(9):849-55. PubMed ID: 23904343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rhabdoid tumor predisposition syndrome.
    Sredni ST; Tomita T
    Pediatr Dev Pathol; 2015; 18(1):49-58. PubMed ID: 25494491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent insights into the SWI/SNF complex and the molecular mechanism of hSNF5 deficiency in rhabdoid tumors.
    Kuwahara Y; Iehara T; Matsumoto A; Okuda T
    Cancer Med; 2023 Aug; 12(15):16323-16336. PubMed ID: 37317642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BAFfling pathologies: Alterations of BAF complexes in cancer.
    Arnaud O; Le Loarer F; Tirode F
    Cancer Lett; 2018 Apr; 419():266-279. PubMed ID: 29374542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SMARCB1-deficient Tumors of Childhood: A Practical Guide.
    Pawel BR
    Pediatr Dev Pathol; 2018; 21(1):6-28. PubMed ID: 29280680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonsense mutation and inactivation of SMARCA4 (BRG1) in an atypical teratoid/rhabdoid tumor showing retained SMARCB1 (INI1) expression.
    Hasselblatt M; Gesk S; Oyen F; Rossi S; Viscardi E; Giangaspero F; Giannini C; Judkins AR; Frühwald MC; Obser T; Schneppenheim R; Siebert R; Paulus W
    Am J Surg Pathol; 2011 Jun; 35(6):933-5. PubMed ID: 21566516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular genetics of atypical teratoid/rhabdoid tumor.
    Biegel JA
    Neurosurg Focus; 2006 Jan; 20(1):E11. PubMed ID: 16459991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SWI/SNF Complex-deficient Undifferentiated/Rhabdoid Carcinomas of the Gastrointestinal Tract: A Series of 13 Cases Highlighting Mutually Exclusive Loss of SMARCA4 and SMARCA2 and Frequent Co-inactivation of SMARCB1 and SMARCA2.
    Agaimy A; Daum O; Märkl B; Lichtmannegger I; Michal M; Hartmann A
    Am J Surg Pathol; 2016 Apr; 40(4):544-53. PubMed ID: 26551623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SMARCB1-mediated SWI/SNF complex function is essential for enhancer regulation.
    Wang X; Lee RS; Alver BH; Haswell JR; Wang S; Mieczkowski J; Drier Y; Gillespie SM; Archer TC; Wu JN; Tzvetkov EP; Troisi EC; Pomeroy SL; Biegel JA; Tolstorukov MY; Bernstein BE; Park PJ; Roberts CW
    Nat Genet; 2017 Feb; 49(2):289-295. PubMed ID: 27941797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rhabdoid tumors: an initial clue to the role of chromatin remodeling in cancer.
    Lee RS; Roberts CW
    Brain Pathol; 2013 Mar; 23(2):200-5. PubMed ID: 23432645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glioma tumor suppressor candidate region gene 1 (GLTSCR1) and its paralog GLTSCR1-like form SWI/SNF chromatin remodeling subcomplexes.
    Alpsoy A; Dykhuizen EC
    J Biol Chem; 2018 Mar; 293(11):3892-3903. PubMed ID: 29374058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SWI/SNF chromatin remodeling complexes and cancer.
    Biegel JA; Busse TM; Weissman BE
    Am J Med Genet C Semin Med Genet; 2014 Sep; 166C(3):350-66. PubMed ID: 25169151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.